Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00835055

Enrollment

Registered

2009-02-03

Start date

2005-04-30

Completion date

2019-04-01

Last updated

2019-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

rectal cancer with neoadjuvant treatment, standardized clinical tests, tumor markers on tumor tissue

Brief summary

The purpose of this study is to determine whether markers on tumor tissue may be an indicator for good response to neoadjuvant chemoradiotherapy in patients with rectal cancer.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* locally advanced rectal cancer uT3 or uT4 * no distant metastasis * neoadjuvant radiochemotherapy required

Exclusion criteria

* rejection of radiochemotherapy

Countries

Switzerland

Outcome results